Business Description
CytoMed Therapeutics Ltd
ISIN : SGXZ17669631
Description
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 15.15 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | -0.16 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -35.5 | |||||
| 3-Year EPS without NRI Growth Rate | -26.6 | |||||
| 3-Year FCF Growth Rate | -48.1 | |||||
| 3-Year Book Growth Rate | 181 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.41 | |||||
| 9-Day RSI | 51.6 | |||||
| 14-Day RSI | 52.17 | |||||
| 6-1 Month Momentum % | 9.15 | |||||
| 12-1 Month Momentum % | -46.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 21.52 | |||||
| Quick Ratio | 21.52 | |||||
| Cash Ratio | 18.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.8 | |||||
| Shareholder Yield % | 4.74 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -26.66 | |||||
| ROA % | -24.79 | |||||
| ROIC % | -122.17 | |||||
| ROC (Joel Greenblatt) % | -107.44 | |||||
| ROCE % | -25.57 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.96 | |||||
| Price-to-Tangible-Book | 3.97 | |||||
| EV-to-EBIT | -10.08 | |||||
| EV-to-EBITDA | -11.37 | |||||
| EV-to-FCF | -9.69 | |||||
| Price-to-Net-Current-Asset-Value | 5.73 | |||||
| Price-to-Net-Cash | 6.97 | |||||
| Earnings Yield (Greenblatt) % | -9.92 | |||||
| FCF Yield % | -7.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GDTC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CytoMed Therapeutics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.196 | ||
| Beta | 0 | ||
| Volatility % | 88.63 | ||
| 14-Day RSI | 52.17 | ||
| 14-Day ATR ($) | 0.34817 | ||
| 20-Day SMA ($) | 2.598165 | ||
| 12-1 Month Momentum % | -46.33 | ||
| 52-Week Range ($) | 1.2 - 5.5 | ||
| Shares Outstanding (Mil) | 11.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CytoMed Therapeutics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CytoMed Therapeutics Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
CytoMed Therapeutics Ltd Frequently Asked Questions
What is CytoMed Therapeutics Ltd(GDTC)'s stock price today?
The current price of GDTC is $2.58. The 52 week high of GDTC is $5.50 and 52 week low is $1.20.
When is next earnings date of CytoMed Therapeutics Ltd(GDTC)?
The next earnings date of CytoMed Therapeutics Ltd(GDTC) is 2025-04-29 Est..
Does CytoMed Therapeutics Ltd(GDTC) pay dividends? If so, how much?
CytoMed Therapeutics Ltd(GDTC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers